About (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine
(2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine (PubChem CID 99926108) has the molecular formula C16H21N7O2
and a molecular weight of 343.39 g/mol. Its IUPAC name is (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine.
Molecular Properties
| Compound Name | (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine |
| PubChem CID | 99926108 |
| Molecular Formula | C16H21N7O2 |
| Molecular Weight | 343.39 g/mol |
| Exact Mass | 343.18 |
| IUPAC Name | (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine |
| SMILES | COCCn1nnnc1[C@H]1CN(Cc2nc3ccccc3[nH]2)CCO1 |
| InChI | InChI=1S/C16H21N7O2/c1-24-8-7-23-16(19-20-21-23)14-10-22(6-9-25-14)11-15-17-12-4-2-3-5-13(12)18-15/h2-5,14H,6-11H2,1H3,(H,17,18)/t14-/m1/s1 |
| InChIKey | GJIFMDWJZCZEKA-CQSZACIVSA-N |
| XLogP | 0.77 |
| TPSA | 93.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 343.39 |
| LogP ≤ 5 | 0.77 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine?
The IUPAC name of (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine (CID 99926108) is (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine.
What is the SMILES notation for (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine?
The canonical SMILES for (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine is COCCn1nnnc1[C@H]1CN(Cc2nc3ccccc3[nH]2)CCO1.
What is the InChIKey of (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine?
The InChIKey is GJIFMDWJZCZEKA-CQSZACIVSA-N. The full InChI is InChI=1S/C16H21N7O2/c1-24-8-7-23-16(19-20-21-23)14-10-22(6-9-25-14)11-15-17-12-4-2-3-5-13(12)18-15/h2-5,14H,6-11H2,1H3,(H,17,18)/t14-/m1/s1.
What are the key properties of (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine?
(2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine has a molecular weight of 343.39 g/mol, XLogP of 0.77, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-4-(1H-benzimidazol-2-ylmethyl)-2-[1-(2-methoxyethyl)tetrazol-5-yl]morpholine is sourced from PubChem (CID 99926108), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).